{"id":436656,"title":"Drugs for rare diseases bilateral agreements - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T16:23:20.899000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/corporate/transparency/health-agreements/shared-health-priorities/drugs-for-rare-diseases-bilateral-agreements.html?wbdisable=true","snippet":"Drugs for rare diseases bilateral agreements On March 22, 2023, we announced up to $1.5 billion over the next 3 years in support of the first-ever National Strategy for Drugs for Rare Diseases . This funding will help increase access to and affordability of effective drugs for…","rawSnapshotUrl":"/api/snapshots/raw/436656","browseUrl":"https://replay.healtharchive.ca/job-6/20260102162320/https://www.canada.ca/en/health-canada/corporate/transparency/health-agreements/shared-health-priorities/drugs-for-rare-diseases-bilateral-agreements.html?wbdisable=true#ha_snapshot=436656","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}